# Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis

> **NCT01331603** · — · UNKNOWN · sponsor: **Wolfson Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Myelodysplastic Syndrome
- Primary Myelofibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01331603
- **Lead sponsor:** Wolfson Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331603, "Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01331603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*